Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal allopurinol for reducing post-hypoxic-ischemic reperfusion damage in newborns
2006-005796-18Phase 3Active
- Sponsor
- Wilhelmina Children's Hospital
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asphyxia neonatorum and hypoxic-ischemic encephalopathy (HIE) comparing Allopurinol antenatal treatment with Placebo antenatal treatment (2 arms). Primary endpoints: Free radical production and Markers of neuronal damage. Started May 2009; status: active.
02
Drugs
allopurinol
03
Conditions
asphyxia neonatorumhypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on 2006-005796-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005796-18.